The trademark Oxycate was filed by NTNU Fakultet for medisin og helsevitenskap, Institutt for sirkulasjon og bildediagnostikk, a corporation established under the laws of the Kingdom of Norway (the "Applicant") and St Olavs Hospital Klinikk for anestesi og intensivmedisin, a corporation established under the laws of the Kingdom of Norway (the "Co-Applicant", and jointly with the "Applicant" referred to as the "Applicants" going forward). The application was published for oppositions on September 10, 2023, and received one opposition filed on November 16, 2023 by OxyCare GmbH Sauerstoff- und Beatmungstechnik on Likelihood of confusion. the opponent was represented by MEISSNER BOLTE PATENTANWÄLTE RECHTSANWÄLTE PARTNERSCHAFT MBB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued November 16, 2023
The application was filed in English, and English was also language of all opposition proceedings (Italian was selected as the second language).